SMi is proud to present the 21st Annual Pain Therapeutics Virtual Conference on 10th and 11th May 2021.

The global Postoperative Pain Therapeutics Market was valued at USD 11.26 Million in 2018 and is projected to reach USD 15.87 Million by 2026, growing at a CAGR of 4.40 % from 2019 to 2026. Chronic pain is a major health care problem that affects some 30%-50% of the world population and almost 20% of Europeans suffer from chronic or intermittent pain; the latter results in suffering and disability for patients and increasing economic loss for society.

The 21st Annual Conference will provide insights into cutting edge drug discovery science, preclinical development trends and will explore novel pain drug targets and novel biomarkers. Join Europe's leading Pain Therapeutics Conference which will analyse the latest developments in the field of pain drug development and learn how to industry is working to overcome the challenges of opioid base treatment.